Chunyang Liu Selected Research

paclobutrazol

3/2022

Study on endocrine disruption effect of paclobutrazol and uniconazole on the thyroid of male and female rats based on lipidomics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunyang Liu Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 01/2013
5	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2013
2	Hyperthermia 01/2022 - 10/2021
2	Cardiomegaly (Heart Hypertrophy) 09/2011 - 05/2009
1	Sarcoma (Soft Tissue Sarcoma) 03/2022
1	Thymoma (Thymic Carcinoma) 03/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Airway Remodeling 01/2022
1	Hematoma 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 10/2021
1	Medulloblastoma 01/2021
1	Meningioma (Meningiomas) 01/2021
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Carcinogenesis 01/2021
1	Poisoning 05/2013
1	Colitis 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2009
2	Therapeutic UsesIBA 01/2022 - 04/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 04/2020
2	HydrogelsIBA 01/2021 - 04/2020
2	LigandsIBA 01/2020 - 11/2017
2	Estrogen ReceptorsIBA 12/2013 - 01/2013
1	paclobutrazolIBA 03/2022
1	uniconazoleIBA 03/2022
1	Insulin-Like PeptidesIBA 03/2022
1	Mitogen-Activated Protein KinasesIBA 03/2022
1	ErbB Receptors (EGF Receptor)IBA 03/2022
1	Tirapazamine (SR 4233)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022
1	MetalsIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Photosensitizing Agents (Photosensitizers)IBA 01/2022
1	ProdrugsIBA 01/2022
1	IonsIBA 10/2021
1	NivolumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	pembrolizumabIBA 01/2021
1	Beclin-1IBA 11/2017
1	Cathepsin BIBA 11/2017
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 11/2017
1	AcidsIBA 11/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017
1	Messenger RNA (mRNA)IBA 11/2017
1	Tamoxifen FDA LinkGeneric 12/2013
1	taxaneIBA 06/2013
1	AnthracyclinesIBA 06/2013
1	NitrogenIBA 05/2013
1	AmmoniaIBA 05/2013
1	EnzymesIBA 01/2013
1	Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)IBA 01/2013
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2013
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2013
1	Phenobarbital (Luminal)FDA Link 01/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Polysaccharides (Glycans)IBA 01/2013
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2013
1	Phospholipases A2 (Phospholipase A2)IBA 01/2013
1	Glycogen Synthase (Synthase I)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2011
1	Fibrinogen (Factor I)FDA Link 05/2009
1	Toll-Like Receptor 4IBA 05/2009
1	NF-kappa B (NF-kB)IBA 05/2009

Therapy/Procedure

5	Therapeutics 01/2022 - 04/2020
3	Drug Therapy (Chemotherapy) 01/2022 - 06/2013
2	Immunotherapy 01/2021 - 01/2020
1	Photothermal Therapy 01/2021
1	Chemoradiotherapy 01/2021